Skip to main content

Table 2 Change in Hgb, ferrtin and TSAT from baseline to 6 months by treatment group

From: Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial

Parameter

HIP baseline

HIP 6 m

p-value

IV iron sucrose baseline

IV iron sucrose 6 m

p-value

Hgb

110.5

117

0.15

108.5

113

0.23

(104–119)

(110–128.8)

 

(102–117)

(107.5-120.3)

 

Ferritin

71

85.5

0.81

67

244

0.003

(40–143)

(44–104)

 

(27–100)

(71.5-298)

 

TSAT

17

21.5

0.05

16.5

21.5

0.04

 

(14–20)

(17–29)

 

(10–20)

(17–27)